|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Recursion Pharmaceuticals (NASDAQ: RXRX) through any online brokerage.
The latest price target for Recursion Pharmaceuticals (NASDAQ: RXRX) was reported by SVB Leerink on May 11, 2021. The analyst firm set a price target for 33.00 expecting RXRX to fall to within 12 months (a possible -9.42% downside). 5 analyst firms have reported ratings in the last year.
The stock price for Recursion Pharmaceuticals (NASDAQ: RXRX) is $36.43 last updated Fri Jun 18 2021 20:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Recursion Pharmaceuticals.
There is no upcoming split for Recursion Pharmaceuticals.
Recursion Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.